GDF15 and primary progressive multiple sclerosis: In line with this, a previous study reported no change in CSF GDF-15 levels or clinical outcomes in PPMS patients after treatment with idebenone, a drug designed to alleviate mitochondrial electron-transport chain dysfunction [21].